New Research Reports

Safari's Q1FY26 performance exceeded our expectations. Sales grew 17% YoY to Rs5.3bn, driven by strong volume growth (up 17% YoY), while realizations remained flat YoY - indicating easing price competition. As a result, gross margin expanded by 128bps YoY to 45.8% but declined 344bps QoQ on higher share of low margin products. EBITDA grew by 20% YoY to Rs793mn, with EBITDA margin expanding by 38bps YoY to 15.0%, supported by higher gross margins despite higher A&P spends (7% vs. 5.5% in Q1FY24). PAT increased by 14% YoY to Rs505mn. We expect revenue/EBITDA/PAT to grow at a CAGR of 14%/26%/29%...

Cyient DLM’s Q1FY26 performance was a sharp miss to our estimates, led by a decline in defense segment, driven by completion of a order from a large customer last year.

Far better realizations led to Stylam’s Q1 revenue surging 16.7% y/y to Rs 2.8bn, even as offtake was lower. Gross profit rose 16.8% y/y to Rs1.3bn.

In Q1FY26, Blackbuck’s core business growth accelerated to ~40% YoY vs. I-Sec est. of 33% YoY. This was driven by higher uptake in value-added services in payments and growth in telematics (regulatory tailwinds).

Avalon Technologies (AVALON IN) has reported strong revenue growth of Change in Estimates | Target | Reco 62.1% YoY mainly driven from Mobility/Industrial segments (grew by ~92%/85% YoY). EBITDA margin expanded by healthy ~710bps YoY to 9.2%,...

JK Paper Ltd.'s (JK Paper) Q1FY26 result was broadly in-line with estimates on net sales and EBITDA front, while net profit was below our forecast. The Company's core business in Paper and Paper Board continued to face headwinds from cheap imports resulting in depressed sales realization and ongoing high domestic wood prices weighed on operating margin. Despite this, JK Paper improved its profits on a sequential basis. The management believes that packaging conversion business is amongst the fastest growing segments in the Indian Paper and Packaging industry driven by growth in end use industries....

GR Infra reported a steady quarter in Q1FY26 with revenue at INR 18bn (-4% YoY), EBITDA at INR 2.3bn (-6% YoY) and margin at 12.7% (-35bps YoY). Adj. PAT stood at INR 2.1bn (+7% YoY).

HealthCare Global Enterprises’ (HCG) Q1FY26 result was in line with our expectations. Revenue grew 16.7% YoY driven by new centres in Mumbai (+28% YoY), Kolkata (+17% YoY) and Ahmedabad (+22% YoY) while key cluster of Karnataka and East India grew at a moderate pace.

We maintain our BUY recommendation on the stock.

We maintain our BUY rating on the company.